Aerie Pharmaceuticals Inc

RHUMBLINE ADVISERS

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/10/2022

Shares

79,568

Value ($000)

1,204

Weight

0.0%

2019 Q4 - 2022 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/10/2022	1,204	0.0%	79,568	9/30/2022
2022 Q2	8/11/2022	506	0.0%	67,469	6/30/2022
2022 Q1	5/12/2022	451	0.0%	49,583	3/31/2022
2021 Q4	2/10/2022	340	0.0%	48,426	12/31/2021
2021 Q3	11/12/2021	546	0.0%	47,933	9/30/2021
2021 Q2	8/5/2021	735	0.0%	45,880	6/30/2021
2021 Q1	5/6/2021	825	0.0%	46,182	3/31/2021
2020 Q4	2/10/2021	687	0.0%	50,850	12/31/2020
2020 Q3	11/12/2020	583	0.0%	49,504	9/30/2020
2020 Q2	8/13/2020	935	0.0%	63,351	6/30/2020
2020 Q1	5/6/2020	807	0.0%	59,758	3/31/2020
2019 Q4	2/5/2020	1,465	0.0%	60,608	12/31/2019